Navigation Links
BioMS Medical updates University of Alberta equity position
Date:4/30/2010

Toronto Stock Exchange Symbol: MS

EDMONTON, April 30 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), today announced that the University of Alberta, a major shareholder of the Company, has sold 12,915,365 BioMS Medical shares.

Certain employees, officers and directors of BioMS Medical acquired 7,245,000 of the shares sold by the University of Alberta.

"We are very pleased that many of our senior management and Board members saw this as an opportunity to purchase these shares, recognizing the long-term prospects for the Company," said Kevin Giese, President and CEO of BioMS Medical. "We also thank the University of Alberta for their support over the past 10 years and continued involvement as a shareholder."

University of Alberta Vice President (Finance) Phyllis Clark added: "We have enjoyed a long and collaborative relationship with BioMS which we look forward to continuing in the future. The proceeds from the sale will be used to support the endowment fund and the teaching and research mission of the university."

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the investment, development and commercialization of pharmaceutical technologies. For further information please visit our website at http://www.biomsmedical.com

This press release may contain forward-looking statements, which reflect the Corporation's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time to time in the Corporation's ongoing quarterly and annual reporting. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioMS Medical Announces 2009 Year End Results
2. BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19.5 million
3. Spectral diagnostics Raises $14 million and enters into strategic collaboration with BioMS Medical to commercialize treatment for sepsis
4. BioMS Medical provides corporate update
5. BioMS Medical Announces Third Quarter 2009 Results
6. BioMS Medical announces second quarter 2009 results
7. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
8. BioMS Medical to participate in panel session at Bio International Convention 2009
9. BioMS Medical Announces First quarter 2009 results
10. BioMS Medical to present at Alberta Economic Forum in Geneva
11. BioMS Medical to present at BioFinance 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... Looking for a ... Diego’s premiere hands-on cooking experience. Offering everything from gourmet cooking classes to weekend ... won’t forget. , Guests that visit LaJollaCooks4u share an experience unlike any other. ...
(Date:5/4/2016)... , ... May 04, 2016 , ... PBI-Gordon Corporation is ... Agricultural Sales. , Doug began his career at PBI-Gordon in February 1988, after ... a wide variety of roles, ranging from customer service to national product manager, to ...
(Date:5/3/2016)... ... May 03, 2016 , ... Leading CEOs ... on May 31st and June 1st at The Four Seasons Hotel Boston. , ... the life sciences, offering exclusive access to key decision makers who influence deal ...
(Date:5/3/2016)... , May 3, 2016  Dr. Thomas ... surgeon in The Woodlands, Texas , ... 24 percent of treated fat cells in just 25-minutes, ... Close to 90 percent of Americans report feeling bothered ... Nonsurgical fat reduction procedures are a growing industry. This ...
Breaking Biology Technology:
(Date:3/9/2016)... NEW YORK , March 9, 2016 ... current and future states of the RNA Sequencing (RNA ... in segments such as instruments, tools and reagents, data ... Analyze various segments of the RNA-Sequencing market such ... RNA-Sequencing services Identify the main factors affecting each segment ...
(Date:3/3/2016)... Calif. , March 3, 2016  FlexTech, a ... the categories of Innovation, Research & Development, Leadership in ... Leadership. This is the 9 th year of ... group of companies and individuals from past years ... based on a pre-described set of criteria, by a ...
(Date:3/2/2016)... 2016 http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) ... "Global Biometrics as a Service Market 2016-2020" ... --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced the ... a Service Market 2016-2020" report to ... and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has announced ...
Breaking Biology News(10 mins):